313 related articles for article (PubMed ID: 15561778)
1. Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma.
Vanasse GJ; Winn RK; Rodov S; Zieske AW; Li JT; Tupper JC; Tang J; Raines EW; Peters MA; Yeung KY; Harlan JM
Mol Cancer Res; 2004 Nov; 2(11):620-31. PubMed ID: 15561778
[TBL] [Abstract][Full Text] [Related]
2. Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma.
Cho-Vega JH; Rassidakis GZ; Amin HM; Tsioli P; Spurgers K; Remache YK; Vega F; Goy AH; Gilles F; Medeiros LJ
Leukemia; 2004 Nov; 18(11):1872-8. PubMed ID: 15385932
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SOCS3 is associated with decreased survival in a cohort of patients with de novo follicular lymphoma.
Krishnadasan R; Bifulco C; Kim J; Rodov S; Zieske AW; Vanasse GJ
Br J Haematol; 2006 Oct; 135(1):72-5. PubMed ID: 16939500
[TBL] [Abstract][Full Text] [Related]
4. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
[TBL] [Abstract][Full Text] [Related]
5. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
[TBL] [Abstract][Full Text] [Related]
6. Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation.
Symmans WF; Katz RL; Ordoñez NG; Dalton H; Romaguera JE; Cabanillas F
Acta Cytol; 1995; 39(4):673-82. PubMed ID: 7631541
[TBL] [Abstract][Full Text] [Related]
7. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 confers efficient viral replication.
Yokota S; Yokosawa N; Okabayashi T; Suzutani T; Fujii N
Virology; 2005 Jul; 338(1):173-81. PubMed ID: 15939448
[TBL] [Abstract][Full Text] [Related]
8. Expression of STAT3 and SOCS3 in pancreatic acinar cells.
Vona-Davis LC; Frankenberry KA; Waheed U; Peterson E; McFadden DW
J Surg Res; 2005 Jul; 127(1):14-20. PubMed ID: 15893771
[TBL] [Abstract][Full Text] [Related]
9. BCL-6 protein is expressed in germinal-center B cells.
Cattoretti G; Chang CC; Cechova K; Zhang J; Ye BH; Falini B; Louie DC; Offit K; Chaganti RS; Dalla-Favera R
Blood; 1995 Jul; 86(1):45-53. PubMed ID: 7795255
[TBL] [Abstract][Full Text] [Related]
10. The pattern and frequency of t(14;18) translocation and immunophenotype in Asian follicular lymphoma.
Peh SC; Shaminie J; Tai YC; Tan J; Gan SS
Histopathology; 2004 Nov; 45(5):501-10. PubMed ID: 15500654
[TBL] [Abstract][Full Text] [Related]
11. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.
Barclay JL; Anderson ST; Waters MJ; Curlewis JD
Mol Endocrinol; 2007 Oct; 21(10):2503-15. PubMed ID: 17609438
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma.
Szereday Z; Csernus B; Nagy M; László T; Warnke RA; Matolcsy A
Am J Pathol; 2000 Mar; 156(3):1017-24. PubMed ID: 10702417
[TBL] [Abstract][Full Text] [Related]
13. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
Bellido M; Capello D; Altés A; Estivill C; Gaidano G; Pujol R; Bordes R; Baiget M; Saglio G; Sierra J; Nomdedéu JF
Haematologica; 2002 Sep; 87(9):908-17. PubMed ID: 12217802
[TBL] [Abstract][Full Text] [Related]
14. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
15. Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups.
Marafioti T; Copie-Bergman C; Calaminici M; Paterson JC; Shende VH; Liu H; Baia M; Ramsay AD; Agostinelli C; Brière J; Clear A; Du MQ; Piccaluga PP; Masir N; Nacheva EP; Sujobert P; Shanmugam K; Grogan TM; Brooks SP; Khwaja A; Ardeshna K; Townsend W; Pileri SA; Haioun C; Linch D; Gribben JG; Gaulard P; Isaacson PG
Histopathology; 2013 May; 62(6):860-75. PubMed ID: 23509938
[TBL] [Abstract][Full Text] [Related]
16. SOCS3 negatively regulates IL-6 signaling in vivo.
Croker BA; Krebs DL; Zhang JG; Wormald S; Willson TA; Stanley EG; Robb L; Greenhalgh CJ; Förster I; Clausen BE; Nicola NA; Metcalf D; Hilton DJ; Roberts AW; Alexander WS
Nat Immunol; 2003 Jun; 4(6):540-5. PubMed ID: 12754505
[TBL] [Abstract][Full Text] [Related]
17. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
[TBL] [Abstract][Full Text] [Related]
18. Loss of interferon-induced Stat1 phosphorylation in activated T cells.
Van De Wiele CJ; Marino JH; Whetsell ME; Vo SS; Masengale RM; Teague TK
J Interferon Cytokine Res; 2004 Mar; 24(3):169-78. PubMed ID: 15035850
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
Limpens J; de Jong D; van Krieken JH; Price CG; Young BD; van Ommen GJ; Kluin PM
Oncogene; 1991 Dec; 6(12):2271-6. PubMed ID: 1766674
[TBL] [Abstract][Full Text] [Related]
20. SOCS3 regulates the plasticity of gp130 signaling.
Lang R; Pauleau AL; Parganas E; Takahashi Y; Mages J; Ihle JN; Rutschman R; Murray PJ
Nat Immunol; 2003 Jun; 4(6):546-50. PubMed ID: 12754506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
